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Summary 
       Mostly Will Roger`s phenomenon means existence of so-called "jumping" or "jumping over the stages" 
regional metastases in the stomach cancer patients. N1 in the 6th edition means 16 regional lymph nodes 
involvement, while the N1 seventh edition – only 1-2 of regional lymph nodes involvement. This means that 
T1N1Mo \ 6th and T1N1Mo \ 7th - not quite the same, and the survival of the two groups will be different. 
The study, made on the abdominal oncosurgical department of Odessa Regional Oncology Center, included 
188 patients operated for gastric cancer in the period 2007-2011. The study included only radically treated 
patients. Comparison of survival in patients with gastric cancer between 6th revision groups of 7th has been 
reviewed. The classification mission is to provide differences in the survival rates between the groups. 
Regression multivariate Cox analysis showed that 7th UICC classification showed different capability of 
stratifying survival groups of UICC N classification (P \ 0.01). 
 
        Key words: extended lymphatic dissection, TNM classification, Will Roger`s phenomenon, 
stomach cancer. 
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         Introduction 
         Mostly Will Roger`s phenomenon means existence of so-called "jumping" or "jumping over the 
stages" regional metastases in the stomach cancer patients. For example, sentinel lymph node biopsy in the 
breast cancer, extended lymphatic dissection is considered inadvisable in the case of negative pathological 
report of removed sentinel lymphatic collector. Тhus Holsted`s conception dominates: cancer cells 
dissemination along those lymphatic collectors occures gradually and consistently. The missing of the 
coming lymphatic step or barrier does not take place, tumor cells must initially fully handle the previous 
metastatic niche, in order to prepare the following and move farther. The next locoregional site cannot be 
affected, if the previous is not still completely mastered. The same is correct for some other type of 
malignant tumors, e.g., skin melanoma.  
          In medical literature 4 common directions of lymphogenic cancer dissemination are distinguished  
(Melnikov А.V., 1960), each of those has also for 4 steps of development: 
        1st direction - the outflow of lymph takes place from greater curvature of pyloric part, and its front and 
back walls. Steps: а) gastrocolic ligament; b) retropyloric lymph nodes; c) mesentery of initial part of small 
bowel; d) paraaortal lymph nodes;  
       2nd direction is the outflow of lymphatic liquid from lesser curvature of pyloric part of stomach and 
close front and back walls. Stages: on lesser curvature - а) throughout right gastric artery - b) hepato-
duodenal ligament; c) hillus of liver - d) lymph nodes, directly into a liver`s hillus;  
       3rd direction includes outflow of lymph from the body of stomach, cardiac part of minor curvature, 
medial part of stomach. Stages: а) omentum minor - b) gastro-pancreatic ligament - c) extraperitoneal upper 
pancreatic and paraaortal lymph nodes - d) mediastinum and periesophageal lymph nodes above diaphragm;  
       4th direction includes outflow of lymph from the vertical part of greater curvature, its front and back 
walls, considerable part of stomach fundal part. Stages: а) gastro-colic ligament - b) gastro-lienal ligament - 
c) gate of spleen - d) spleen. 
         Existence of the phenomenon of  "jumping" stomach cancer metastases is well-proven by many 
researchers [1,2] and does the biopsy of sentinel lymph node ineffective. Therefore the first place takes not 
the sentinel lymphatic node identification but implementation of prophylactic biopsy as possible wide 
amount of near-by lymphatic nodes, prophylactic lymphatic dissection.  
         It is, therefore, considered that removal less than 16 lymph nodes provides incorrect staging. Adequate 
staging might be improper even in the case of proper dissection (D2), by reason of mathematical law – Will 
Rodger's phenomenon  [1,2], that in the appliance to the stomach cancer means the presence of "springing" 
or "jumping" over one of the stages regional metastases. 
       Interestingly, that initially the phenomenon of Will Rodger's had no attitude toward migration of the 
stage and to medicine in general, and touched a seeming paradox (focus), consisting in that transferring 
(numeral) of element from one great number in other can increase the mean value of both great numbers.  
       For the best illustration of this widespread phenomenon we will consider two great numbers, X and Y : 
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X = {1, 2, 3, 4}, 
Y = {5, 6, 7, 8, 9}. 
Arithmetic sum of elements of X is equal to elements of Y = 7. 
However, if number 5 to transfer from X in Y, getting 
X = {1, 2, 3, 4, 5}, 
Y = {6, 7, 8, 9}, 
the calculation that mean value of elements of X will rise to 3, and mean value of elements of Y - to 7,5. 
 
 
        Image 1. Will Rodger has an authorship of so well-known in biology phenomenon. 
 
         Because these people are not healthy, removing them from the set of healthy people increases the 
average lifespan of the healthy group. Likewise, the migrated people are healthier than the people already in 
the unhealthy set, so adding them raises the average lifespan of that group as well. Both lifespans are 
statistically lengthened, even if early detection of a cancer does not lead to better treatment: because it is 
detected earlier, more time is lived in the "unhealthy" set of people.  Adding of them to the great number 
promotes the middle index of health [1]. Classification of the same group of oncologic patients 
simultaneously according 6th and 7th variants of revision of classification of TNM appropriately will cause 
the outflow of part of patients from one stage into other.  And that, in turn, is able to change the indexes of 
survivability the same, it would seem, groups of patients. 
     Background 
      Thus, Sumin Chae et al. compared the efficacy of 7th TNM classification in comparison with the 5th \ 
6th, as a factor in the prognosis of gastric cancer. It is concluded that the number of affected lymph nodes is 
a major prognostic factor. The study was conducted to assess the rationality of [7] 7th revision of the 
International Classification comparison with 6th classification. Analyzed 295 patients included in the study 
for four years. In accordance with the seventh edition of the UICC, N classification, 5-year cumulative 
survival for N0, N1, N2, N3a and N3b totaled 89.7, 73.6, 54.9, 23.1 and 5.4%, respectively (P \ 0.0001). 
Using univariate analysis, it was concluded that the N classification of the seventh and sixth UICC / AJCC 
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TNM staging system, T-seventh classification of UICC TNM staging system, the size and location of the 
tumor, as well as histology, were significantly associated with overall survival for gastric cancer. At the 
same time, regression multivariate Cox analysis showed that 7th UICC N classification was an independent 
prognostic factor instead of six UICC N classification (P \ 0.0001). 
       N1 in the 6th edition means 16 regional lymph nodes involvement, while the N1 seventh edition – only 
1-2 of regional lymph nodes involvement. This means that T1N1Mo \ 6th and T1N1Mo \ 7th - not quite the 
same, and the survival of the two groups will be different. This group of patients previously classified as 
now will be in a different stage of the disease and thus shifts the statistics of the stage. These are the "Okies" 
of Will Roger who moved from Oklahoma to California: 
                                                                                    N1 \7
th
 edition 
            N1 \6
th
 edition:                                                 N2 \7
th
 edition   
 
       Thus, summing up the results of a point, we can say that studying phenomenon exists as if in three 
dimensions, three senses. In the conventional sense it means those jumping, biologically aggressive 
"penetrating" metastases. In a wider sense - it transfers patients from one to another  stage of the 
classification while changing the method of describtion. And here and there "okies" Will Roger moved from 
Oklahoma to California, and vice versa. 
       Firstly, it is certainly a great example of how imperfect staging system for cancer in general, and 
particularly for stomach cancer. "Jumping" (better translated "skipping”) lymphotropic metastasis, leading to 
heterogeneous description of the criteria N, and therefore does not fulfill adequate volume of lymph node 
dissection and further therapy. Although who is #1 in this case - the chicken or the egg - inadequate staging 
or a selected volume of lymphatic dissection? 
      Secondly, the very trick of  W. Roger, of course, is contrary to the experience of the observer. Since the 
transfer of at least one number from one group to another leads to a change in all group`s calculations. It 
increases the numeric value of the average of both sets, which means a change of the standard deviation or 
median survival. 
        Finally, in the third. This phenomenon shows the importance of the proper distribution of values in the 
group (i.e. stratification). Because each subsequent new (5th, 6th, 7th, 8th expect) TNM classification 
attempts to stratify gastric cancer patients very differently. Compare staged according to the different 
understanding of the TNM classification in the meta-analyzes can be carried out incorrectly. 
       Sir Robert Maldon, one of the historically known Prime Minister of New Zealand, is famous for the 
phrase "New Zealanders are immigrating to Australia, increase the IQ of both countries." The migration of 
patients to another stage when a classification system has been changed is a really existing event; 
particularly Daniele Marrelli called it “shift” stage [4]. 
       Talking about the phenomenon of migration of patients from stage to stage at different classification of 
the same group, we should make a literary reference. 
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      Shiro Kikuchi et al. [6] studied 609 patients with advanced gastric cancer who underwent extended 
lymphadenectomy. 7th compares the effectiveness of the TNM classification in comparison with the 6th 
classification as a factor in the prognosis of gastric cancer. 5-year survival rate showed no difference in 
survival: IB 88%; II74%; IIIA 53%; IIIB 39%; and IV 18% (IIIA versus IIIB, p = 0.1307) for the TNM VI 
edition; IB 94%; IIA 85%; IIB 71%; IIIA 68%; IIIB 48%; IIIC 23%; and IV 13%; (IIB against IIIA, p = 
0.7665; IIIC against IV, p = 0.4156) for the seventh and TNM JCGC 14th edition; N0 85%; N1 70%; 46% 
N2; N3 18%; M1 and 13%; (N3 against M1, p = 0.8640) for the sixth edition of TNM; N0 and 85%; N1 
80%; 61% N2; N3a 46%; N3b 18%; M1 and 13%; (N0 vs. N1, p = 0.2735; N2 against N3a, p = 0.0663; N3b 
against M1, p = 0.8640) for the seventh and JCGC 14 edition. It is concluded that the classification of 
patients by TNM JCGC seventh and the 14th edition is not always superior to TNM 6th edition to determine 
the prognosis after radical surgery in advanced stage of gastric cancer. Extended lymph node dissection can 
be effective for N0-N3a, but not for N3b and M1 are TNM stages 7th edition and JCGC 14th edition. 
        In our study, the migration of subgroups of patients with gastric cancer from one stage to another, due 
to the change of the descriptive system of staging, led to a decrease in the risk of death by 17% for the 
second stage and 55% - for the third. Compare life expectancy of patients with gastric cancer in groups 
T4aN3aM0 (described by a former version like T3N2M0) and T4bN3M0 (in 6th - T4N2M0) stages revealed 
significant differences in survival. Significant differences were respectively p = 0.00146 and p = 0.0137; 
hazard ratio - 1.12 and 1.11. The difference in median survival was as follows: 22 and 44 months for 
T4aN3aM0 (VII) ≈ T3N2M0 (VI) and the ligaments 28 and 23 months for T4bN3M0 (VII) ≈ T4N2M0 (VI), 
respectively. It is concluded that the movement of the subgroups of patients with gastric cancer TNM-from 
one system to another changed the risk of the event, the death of progression by 12 and 11%, respectively. 
 
               Table 1. Detected shift in survivability of the patients, stratified on the stages in accordance with 
the requirements of  different TNM systems. 
TNM stages, 
6th edition 
TNM stages, 7th 
edition 
The range of differences in survival 
patients with gastric cancer , F test, 
Fisher's exact test 
1st randomization group 2nd randomization group 
I stage I stage Groups appeared minorities 
II stage IIb stage р=0,14>0,05, n=21 р=0,037<0,05, n=20 
IIa stage р=0,054>0,05, n=4 р=0,66>0,05, n=5 
IIIa stage IIIa stage р=0,019<0,05, n=14 р=0,0071<0,05, n=12 
IIIa stage р=0,002<0,05, n=14 р=0,0056<0,05, n=13 
IIIa stage р=0,00025<0,05, n=6 р=0,0001<0,05, n=12 
IIIb stage IIIb stage р=0,0001<0,05, n=6 р=0,0001<0,05, n=27 
IV stage IIIc stage р=0,0001<0,05, n=21 р=0,0001<0,05, n=18 
IIIc stage р=0,01<0,05, n=21 р=0,0002<0,05, n=18 
IIIc stage р=0,04<0,05, n=21 р=0,0003<0,05, n=11 
IIIc stage    р=0,0001<0,05, n=10 р=0,0001<0,05, n=10 
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Various survival of the same subgroup (TNM staging according to different systems) due to the fact 
that the number of patients in the same subgroup TNM has been varied, i.e. there is a shift or migrate 
patients from one subgroup to another. It was expected that no any differences between those groups, since 
it is the same patients. However, different systems of staging offer statistically significant difference in 
survival. 16 evaluations only three cases marked comparable value of patient survival: T3N1M0 (6th) and 
T4aN2M0 (7th), T4N1M0 (6th) and T4bN2M0 (7th), and T4N2M0 (6th) and T4bN3M0 (7th) (p> 0,05).  
 
     Table 2. Differences in the survival of radical operated patients with gastric cancer, stratified by groups 
of TNM. 
TNM stages, 6th 
edition 
TNM stages, 7th 
edition 
The range of differences in survival 
patients with gastric cancer , F test, 
Fisher's exact test 
1st randomization 
group 
2nd randomization 
group 
T2aN1Mo T2N1Mo 
T2N2Mo 
Groups appeared minorities 
T2bN1Mo T3N1Mo 
T3N2Mo 
Groups appeared minorities 
T3N1Mo  
 
T4aN1Mo (n=20) р=0,023<0,05 р=0,00029<0,05 
T4aN2Mo (n=25) р=0,00239<0,05 р=0,072>0,05 
T4N1Mo 
 
T4bN1Mo (n=22) р=0,00468<0,05 р=0,00326<0,05 
T4bN2Mo (n=12) р=0,0164<0,05 р=0,0526>0,05 
T2aN2Mo T2N3Mo Groups appeared minorities 
T2bN2Mo 
T2bN3Mo 
T3N3Mo 
 
Groups appeared minorities 
T3N2Mo T4aN3Mo (n=14) р=0,0147 <0,05 р=0,00018<0,05 
T3N3Mo р=0,0002<0,05 р=0,0002<0,05 
T4N2Mo T4bN3Mo (n=24) р=0,063>0,05 р=0,0137<0,05 
T4N3Mo р=0,00056<0,05 р=0,0001<0,05 
 
        Over the past 10 years the oncological and surgical hospitals experienced a transition from 4th to the 
5th, then the 6th and the coming 7th edition of the International Classification TNM. Could this fact affect 
the statistics and indicators of the quality of treatment of patients with gastric cancer? After all, the process 
took only 10-12 years. Numerous studies in medical literature were established on different classifying 
systems with different variables, e.g. the study of patients with gastric cancer on a fourth stage will now 
correctly be compared now with the 4th only, but also with 3a, 3b, 3c, and even a 2b-th stage. 
       We offer to the attention some differences between the 7th and 6
th
 edition of classification TNM. The 
4th and 5th system of classification are not given here, so as not to clutter up the work. 
       1. Partition index T1 to T1a and T1b stages. 
       2. Subdivision T4 phenotype onto T4a and T4b stages. 
       3. T2a and T2b indexes are now missing, however 2a and 2b stages administered. 
       4. The numerical values of T and N indices gained new qualitative values, which will be discussed 
below. 
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       5. The N3 index is now divided onto N3a & N3b. 
       6. Revision undergone stage 3 and 4: 4th stage now means only the presence of distant metastases; stage 
#3 is divided onto three stages: 3a, 3b, 3c. 
       7. Those TNM-combinations previously meant one stage now refer brand new stages: 
6th
T1 N1 Mo = 
7th
T1а,b N2 Mo 
6th
T2a N1 Mo = 
7th
T2 N2 Mo 
6th
T2b N1 Mo = 
7th
T3 N2 Mo, 
7th
T3N1Mo 
6th
T3 N1 Mo = 
7th
T4a N1 Mo, 
7th
T4a N2 Mo 
6th
T4 N1 Mo = 
7th
T4b N2 Mo 
6th
T1 N2 Mо = 7thT1a,b N3а Mо 
6th
T2a N2 Mo = 
7th
T2 N3а Mo 
6th
T2b N2 Mo = 
7th
T3 N3а Mo 
6th
T3 N2 Mo = 
7th
T4a N3а Mo 
6th
T4 N2 Mo = 
7th
T4b N3а Mo 
6th
T2b N3 Mo = 
7th
T3 N3b Mo 
6th
T3 N3 Mo = 
7th
T4a N3b Mo 
  Without changes or, more correct to say, almost without changes, remained: 
6th
Tis Nо Mо = 7thTis Nо Mо 
6th
T1 Nо Mо = 7thT1a,b Nо Mо 
6th
T1 N1 Mо = 7thT1a,b N1 Mо 
6th
T1 N3 Mо = 7thT1a,b N3b Mо 
6th
T2a N1 Mo = 
7th
T2 N1 Mo 
6th
T2a N3 Mo = 
7th
T2 N3b Mo 
6th
T4 N1 Mo = 
7th
T4b N1 Mo 
6th
T4 N3 Mo =  
7th
T4b N3b Mo 
       Kim S. S. et al. [8] from the University College in Seoul, conducted a retrospective analysis of 266 
patients with gastric cancer who were operated in 2000-2009, found no difference in survival of patients 
classified to 7th edition of the International Classification: between stages IIA and IIB, IIB and IIIA, and 
IIIA and IIIB (70% vs. 71%, p = 0.530; 71% vs. 80%, p = 0.703; 80% vs. 75%, p = 0.576, respectively), 
although the respective statistical difference in 5-year cumulative survival rates were found among classify 
to VI edition. Using T phase 7th version, 5-year survival rates did not differ between T2 and T3 (86% vs. 
82%, p = 0.655). step using N, 5-year survival rates did not differ between N1 and N2, N3a and N3b (79% 
vs. 81%, p = 0.506; 41% vs. 17%, p = 0.895, respectively). Conclusions on that classification 7th is 
relatively worse prognostic possibilities in terms of determining the prognosis of gastric cancer compared 
with 6th edition. 
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       Daniele Marrelli and colleagues. [9] analyzed 2090 patients with non-cardiac gastric cancer who were 
operated in the period 1991-2005. For comparison purposes, simulated evaluation of these patients by 7th 
TNM. Traces the changes in the distribution of patients with gastric cancer in stages in the 6th and 7th TNM 
version. Largely due to the shift of a large number of cases of the IB in stage IIA and of the IIIA and stage 
IV in stage IIIB, and IIIC. Cancer-sensitive 10-year survival was 53% ± 1%. Traces the significant 
differences in T (T2 vs. T3, P <0.001) and N categories (N1 vs. N2, P <0.001). Survival rates N3a subgroup 
(7-15 affected lymph nodes) was significantly better than N3b (> 15 lymph nodes; p <0.001). Stage IB and 
IIA 7th TNM showed a similar forecast, while among the other subgroups revealed significant differences. 
Analysis TNM categories within TNM stages VII showed heterogeneity in survival rates stages IIB, IIIB 
and IV. It is concluded that the seventh classification of AJCC / UICC TNM noncardia for gastric cancer 
shows the subgroup of patients with uneven outlook. Distribution by stages and phases-dependent survival 
has changed significantly compared to the 6th edition. 
      Is it possible, using probability theory, including statistical analysis of the probability of the procedure 
Cox, predict how often the phenomenon of "skipping" gastric cancer regional metastases escapes the 
observer, that is, surgeon, pathologist, chemotherapist? Since during surgery for gastric cancer, this 
phenomenon is not always detected (outermost collectors cannot be excised in all cases). Opportunity is to 
monitor early loco-regional recurrence. migration of patients from stage to stage at different 
lymphadenectomy procedures (D1, D2, D3) and the mathematical prediction of "failures" in the survival of 
patients at different ways of classifying (was used by the 6th and the 7th edition of TNM). The presence of 
"failure" in survival would indicate the presence of residual (left) collectors, even in the absence of loco-
regional recurrence - an evidence of the phenomenon of Will Rogers . The study included patients with no 
evidence of distant metastases. 
       Objectives   
       The objectives of this work were to compare the influence of different types of classification onto 
patients’ survival rate. 
       Materials and methods  
       The study, made on the abdominal oncosurgical department of Odessa Regional Oncology Center, 
included 188 patients operated for gastric cancer in the period 2007-2011. The study included only radically 
treated patients. The average age was 60,6 ± 10,5 years, gender content: men - 120, women - 68. 
 
   Table 3. Distribution of patients with gastric cancer by the age groups. 
№ Age Patients number 
1. 30-39  7 
2. 40-49  21 
3. 50-59 54 
4. 60-69  63 
5. 70-79 35 
6. 80-90  5 
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       Total performed 126 total resection and 62 subtotal gastrectomy. Gastrectomy performed by the method 
of G.V. Bondar means forming a loop terminolateral coupling-like retrocolic esophago-jejunum anastomose 
interintestinal with entero-enteroanastomosis by Brown`s method. Distal subtotal resection in most cases 
finished with the formation retrocolic gastroenteroanastomosis Billroth-2 in Hofmeister-Finsterer 
modification. 
      We studied the life expectancy of patients with gastric cancer included in the study. Information about 
life expectancy has been obtained from the Regional Cancer Registry, updating data is 1 time in 3 months. 
Further, life tables were constructed for each of the group stage and the treatment method used. Survival was 
studied by constructing models of proportional hazards regression risks accorging to D.R.Cox (1972) by the 
formula: 
                           hi (t) = ho (t) x eb1X1 + b2X2 + b3X3 + ... + bnXr where 
h0 (t) – primary risk 
b1 ... bn-regression coefficients 
X1 ... XR-prognostic factors 
When b = 0, hazard ratio is 1. 
 
       The observations were censored: For those patients with gastric cancer, with whom managed to keep in 
touch, censor = 0, if the patient dies, the censor was = 1. In survival analysis examined the frequency of 
events in time - the median survival of patients, i.e., time during which the population of patients with 
gastric cancer is cut in half. The starting point was the date of the operation, the scale of time - months of 
life of patients, the event - the death of the patient. 
      Regional Cancer Registry is an example of so-called censored sample. This term ‘censored’ means a 
sample should be analyzed mathematically, but which, because of objective and subjective reasons, does not 
contain complete information. Kaplan-Meier method, as a method of constructing life tables and other 
methods of dealing with censored samples. He has only one drawback: it does not allow to assess the 
significance of differences between the two survival curves. 
       The standard account of the right censoring - disposal of the patient to follow-up or death from other 
causes; and left clipping - uneven inclusion of patients in the study (patients included in the study in 2007, 
2008, 2009, etc. years). By plotting scale Y - included the percentage of survivors S, and the scale of X - 
months of observation. The advantage of the Cox model is the possibility of adding a covariate, no need to 
properly stratify the group to justify the correctness of stratification in the log-rank (Logistic regression) and 
Kaplan-Mayer mathematical models. 
       The terms "survival analysis" and "cumulative survival" there are generally only for the proportionate 
Roxby James Cox regression. However, even in very serious jobs sometimes we still find the phrase 
"cumulative survival by Kaplan-Meier”.  
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       Indeed, to the Student's t test dimensions compared samples should be greater than 30 observations, 
using Pearson's chi-squared test χ2 chi-square - not less than 20; using Fisher's exact test samples F size has 
virtually no value. For parametric samples necessary to study the law of distribution of feature-group sample 
to prove the existence of interdependence (relationships) between them and approve of the Gaussian 
distribution uniformity characteristic of the group. One of the most famous of tests for normality sign is the 
Kolmogorov-Smirnov test. One way to bring the sample to the normality is its logarithm, as we shall see 
below. 
       Wilcoxon T can be used if sample size of 5 to 50 study participants, while the number of groups should 
be the same. This figure is 50 - is the limit table value, in the case of the use of electronic calculations the 
upper limit is not limited. Criteria Fisher F and Student's t test designed for parametric two related samples 
with normal distibution feature. Wilcoxon T - 2 nonparametric related, for the same sample size (s). 
Pearson's chi-squared test and the nonparametric χ2. For more than 2 (3 or more group-selection) unrelated 
nonparametric samples with different number of members of the criterion Wilcoxon U-Mann-Whitney 
statistics and ANOVA (ANalysis Of Variance). U criterion may be used if the number of members of 
sample-20 - 60, but may be at a lower volume group. 
      Pearson criterion χ2 agreement has a maximum capacity of relative "(very) near" competing hypotheses 
[5]. These competing hypotheses in the case of our study were similar survival curves of patients with the 
same stage, which was removed a different number of lymph nodes. 
       Despite this abundance of different criteria for assessing the validity of the relationship and the 
differences between the samples, the majority of interested researchers will always choose only between 
Fisher criterion F and Pearson χ2. 
      Correlation analysis is carried out using the criteria of the Pearson correlation r (r-Pearson) or Spearman 
r (r-Spearman's). The coefficient ranges from -1 to +1. For medical and biological researches is considered a 
high correlation number - 0.6 or 0.6. The negative correlation is also can be valuable. The value of 0.9 
corresponds to almost absolute correlation between samples. The criterion of Pearson correlation of r and 
Spearman rank correlation criterion r are calculated for groups with a number of members of 5 or more. 
       Another essential to the calculation of indices in such studies is the odds ratio (OR). This unique index 
allows to estimate the probability of both favorable and unfavorable outcome. Thus researcher can predict 
the development of a particular outcome in a clinical trial. For example, if OR = 1 or close to 1, the odds of 
the event in the samples are the same. Axiom: the difference between the samples of groups is uncertain if 
the confidence interval includes 1. Thus, this is another criterion for the evaluation of the accuracy of the 
differences between the groups. In the following result we are often faced with a situation where p was less 
than 0.05, but the confidence interval did not include a digital value 1, which prompted at least not jump to 
negative conclusions. 
       As we have seen from the previous explanation, there is a so-called migration, a transition part of the 
patients from one stage to another TNM. The existence of such a transition has so far been confirmed only 
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speculative conclusion that what had previously been one step in the following classification will be 
different. Once again, let me remind yourself some of these examples. 
 
Т2а \6th Edition                                   Т2 \7th Edition: 
Т2b \6th Edition                                  Т3 \7th Edition 
Т3 \6th Edition                                          Т4а \7th Edition 
Т4 \6th Edition                                          Т4b \7th Edition 
                                                          N1 \7th Edition 
N1 \6th Edition                                  N2 \7th Edition 
                                                                  N1 \7th Edition 
N1 \6th Edition                                         N2 \7th Edition  
N2 \6th Edition                                     N3a \7th Edition 
N3 \6th Edition 
                                                        N3b\7th Edition 
N3 \6th Edition                   
                                                             Т1а \7th Edition 
Т1 \6th Edition             
                                                             Т1b \7th Edition 
Т2а \6th Edition                            Т2 \7th Edition 
Т2b \6th Edition                                  Т3 \7th Edition 
Т3 \6th Edition                                         Т4а \7th Edition 
Т4 \6th Edition                                           Т4b \7th Edition 
 
        Results 
       Attention is drawn to the fact how little in the medical literature drawn attention to the possibility of the 
presence of such a transition. After all, what used to be a stage, after quite simple and clear manipulation 
becomes another step T, N, M, etc. Survival rates of patients has been changed, occur changings in the ratio 
of men / women in groups, changing in the average age of the patients in groups, changing in the type of 
treatment, the patients who were subjected to finally such important descriptive elements, as an average, 
mode, standard deviation, etc. have been changed. 
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        Table 4. Groups, where changing of classification system yielded statistically significant differences 
between the patients survival. 
TNM stages, 
6th edition 
TNM stages, 7th edition The range of differences in survival 
patients with gastric cancer , F test, 
Fisher's exact test 
1st randomization 
group 
2nd randomization 
group 
T3N1Mo  
 
T4aN1Mo (n=20) р=0,023<0,05 р=0,00029<0,05 
T4aN2Mo (n=25) р=0,00239<0,05 р=0,072>0,05 
T4N1Mo 
 
T4bN1Mo (n=22) р=0,00468<0,05 р=0,00326<0,05 
T4bN2Mo (n=12) р=0,0164<0,05 р=0,0526>0,05 
T4N2Mo T4bN3Mo (n=24) р=0,063>0,05 р=0,0137<0,05 
T4N3Mo р=0,00056<0,05 р=0,0001<0,05 
 
        Thus, group T3N1Mo 6th reclassification compared with 2 relevant 7
th
: 
 
T3N1Mo 
 
T4aN1Mo (n=20) 
T4aN2Mo (n=25) 
 
 T4aN1Mo 7th (n=20)     р=0,023<0,05          р=0,00029<0,05 
 T4aN2Mo 7th (n=25)     р=0,00239<0,05          р=0,072>0,05. 
 
      As can be seen, regardless of randomization, when transfer from one classification to another occurs, 
patients had already different survival rate. This means that the so-called "State change" was everywhere, 
except in one case: p = 0.072> 0.05. Suchwise phenomenon occurred where T4N1Mo 6th passed 
comparison with 2 groups of the 7
th
: 
 
T4N1Mo 
 
T4bN1Mo (n=22) 
T4bN2Mo (n=12) 
 
 T4bN1Mo 7th (n=22)  р=0,00468<0,05 р=0,00326<0,05 
 T4bN2Mo 7th (n=12)  р=0,0164<0,05 р=0,0526>0,05 
 
       The same was the case in the other group with 34 patients, where as a result of migration from stage to 
stage the patient’s lifespan changed. Only one of the three calculating comparison showed the absence of 
change: p = 0.0526> 0.05. 
        Other groups were relatively small in number for such comparisons, except as shown in the table 
below. 
T3N2Mo T4aN3Mo (n=14) 
T3N3Mo 
T4N2Mo T4bN3Mo (n=24) 
T4N3Mo 
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       Both T3N2Mo7th and T3N3Mo7th inhere, according to all innovations, now match the another 
description by the seventh edition: T4aN3Mo. 
        Recall that the Fisher's exact test F and χ2 Pearson's chi-squared test can be used to compare the groups 
with only 2 arms. In this numerical (digital) value in such a table by using chi-square test cannot be less than 
5. In the table numerical values were as follows: 
T4aN1Mo (n=20) 
T4aN2Mo (n=25) 
T4bN1Mo (n=22) 
T4bN2Mo (n=12) 
T4aN3Mo (n=14) 
T4bN3Mo (n=24) 
 
       Comparison was performed with a group of 6th revision, which had a similar number of groups of 
digital values. 
        Here phenomenon Will Rodger`s has found regardless of randomization group: p = 0.0147; p = 
0.00018; p = 0.0002; p = 0.0002. Two groups randomization provide higher accuracy of calculations. 
                T3N2Mo 6th    T4aN3Mo 7th (n=14)       р=0,0147 <0,05 р=0,00018<0,05 
                       T3N3Mo 6th                               р=0,0002<0,05 р=0,0002<0,05 
       Six T4N2Mo T4N3Mo and match the description to only two sevens, united under one heading - and it 
T4bN3 (a, b) Mo (N3 = metastasis There are 7 or more regional lymph nodes, T4b = tumor involves 
surrounding structures - OS). Recall: 
N2 \6th Edition: 7-15 mts                           N3a \7th Edition: 7-15 mts 
N3\6th Edition    >16mts 
                                                                          N3b\7th Edition:    >16 mts 
N3\6th Edition    >16mts                  
 
Т4 \6th Edition                                     Т4b \7th Edition 
 
T4N2Mo 6th T4bN3Mo 7th       (n=24)         р=0,063>0,05 р=0,0137<0,05 
T4N3Mo 6th                                                  р=0,00056<0,05  р=0,0001<0,05 
        
  In the randomized group 1 in the case of the transfer of patients from T4N2Mo 6th in T4bN3 (a, b) Mo 7th, 
p = 0.063. With more than 0.05 - "state change" did not happen. Only in this case the introduction of the 7th 
classification did not affect the survival of patients with gastric cancer. In other cases, the desired 
phenomenon was observed and verified. The number of groups of patients was sufficient to assess the 
possibility of such test. 
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      Another way to check the authenticity of our yet purely speculative conclusions on moving patients from 
one classification to another was an attempt to compare their survival depends on the stage. To do this, made 
a similar comparison of mathematical description of stages, as set out in the classifications. 
      Namely. 
0stage TisNоMо \6th  = 0stage TisNоMо\7th 
1а stage T1NоMо \6th  = 1а stage T1a,bNоMо \7th  
1b stage T1N1Mо \6th  = 1b stage T1a,bN1Mо \7th 
1b stage T1N1Mo\6th =2а stageT1а,bN2Mo\7th  
                                                                           2а stage T2N1Mo \7th 
                  2 stage T2aN1Mo \6th                     2b stage T2N2Mo \7th 
        
                                                                              2b stage T3N1Mo \7th 
                      2 stage T2bN1Mo \6th 
                                                                              2b stage T3N2Mo \7th 
        
                                                                            3а stage T4aN1Mo \7th 
                      3а stage T3N1Mo \6th                   3b stage T4aN2Mo \7th 
 
                                                                           3b stage T4bN1Mo \7th 
                          4 stage T4N1Mo \ 6th              3с stage T4bN2Mo \7th 
 
2stage T1N2Mо \6th. =2bstageT1a,bN3аMо\7th 
 3а stage T2aN2Mo \6th. = 3а stage T2N3аMo \7th 
3а stage T2bN2Mo \6th. = 3b stage T3N3аMo \7th  
3b stage T3N2Mo \6th. =  3с stage T4aN3аMo \7th 
4 stage T4N2Mo \6th. = 3с stage T4bN3аMo \7th  
4 stage T1N3Mо\6th. = 2б stage T1a,bN3bMо\7th 
4 stage T2aN3Mo \6th. = 3а stage T2N3bMo \7th 
4 stage T2bN3Mo \6th. = 3б stage T3N3bMo \7th 
4 stage T3N3Mo \6th. = 3с stage T4aN3bMo \7th 
4 stage T4N3Mo \6th. = 3с stage T4bN3bMo \7th 
 
    Table generalized comparison of survival in patients with gastric cancer graphs 6th revision groups of 7th 
review, which also has been randomized. Graphics themselves are not shown in the text to simplify the 
perception of the entire array of information.  
     Table 5. Group, where another method of staging yielded statistically significant differences between 
patients with gastric cancer survival stratified by stage. 
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TNM stages, 
6th edition 
TNM stages, 7th 
edition 
The range of differences in survival 
patients with gastric cancer , F test, 
Fisher's exact test 
1st randomization group 2nd randomization group 
I stage I stage Groups appeared minorities 
II stage IIb stage р=0,14>0,05, n=21 р=0,037<0,05, n=20 
IIa stage р=0,054>0,05, n=4 р=0,66>0,05, n=5 
 
      In this case, the situation with the number of patients in the subgroups was much more prosperous. Only 
the first stage is not pleased with the opportunity to test the theoretical conclusions. 
II stage IIb stage 
IIa stage 
 
         II stage         IIb stage  р=0,14>0,05, n=21 р=0,037<0,05, n=20 
                    IIa stage  р=0,054>0,05, n=4 р=0,66>0,05, n=5 
       Compares II and IIb stages in terms of changing survival for the mathematical verification of transfer 
patients reality from one group to another. 
     II stage IIb stage 21-20=1 
           IIa stage 4-5=-1 
       Only in one case, such a verification has been achieved: p = 0,037 <0,05, n = 20, when comparing the 
first randomized groups belonging to 7 from reclassification. In three other cases, the existence of the 
phenomenon of transition was rejected, but the number of patients there was unsatisfactorily low. Recall that 
it was considered statistically significant p <0.05, enough for biomedical research. Surprisingly, all this 
supreme statistical calculations completely coincided with the simplicity of arithmetic: 1 + 1 = 0. 
 
IIIa stage IIIa stage 
IIIa stage 
IIIa stage 
 
IIIa stage    IIIa stage        р=0,019<0,05, n=14      р=0,0071<0,05, n=12 
IIIa stage                     р=0,002<0,05, n=14      р=0,0056<0,05, n=13 
IIIa stage                     р=0,00025<0,05, n=6       р=0,0001<0,05, n=12 
       The outcome of patients in stage IIIa 7th classification system in exactly the same stage IIIa previous 
classifications in all cases was confirmed. 
       IIIa stage                          14-12=2 
      IIIa stage                          14-13=1 
      IIIa stage                           6-12=-6 
       Will Rodger`s phenomenon here confirmed. Statistical indicators, including the most important from the 
point of view of the oncologist - a change of survival – has been radically changed. In some cases, the 
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accuracy was p <0.001, and in one case even <0.0001. The total number of patients n = 71, provided that the 
use of Fisher's exact test is sufficient to confirm the statistical differences, even though the number of groups 
from 6 to 14. The migration of 2 + 1 + -6 = -3.  
IIIb stage IIIb stage 
 
       The same data was odtained when compared IIIb of 6th stage and IIIb of 7th editions. The resulting 
mathematical parameters are: p = 0.0001 <0.05, n = 6 and p = 0.0001 <0.05, n = 27. 
IV stage IIIc stage 
IIIc stage 
IIIc stage 
IIIc stage 
 
IV stage IIIc stage р=0,0001<0,05, n=21      р=0,0001<0,05, n=18 
          IIIc stage р=0,01<0,05, n=21      р=0,0002<0,05, n=18 
          IIIc stage р=0,04<0,05, n=21       р=0,0003<0,05, n=11 
          IIIc stage р=0,0001<0,05, n=10       р=0,0001<0,05, n=10 
 
       The same data obtained for the transition from IV to IIIc stage. n = 130. Reformatting the group in the 
7th revision led to a radical change in the statistics. p = 0.0001; p = 0.0001; p = 0.01; p = 0.0002; p = 0.04; p 
= 0.0003; p = 0.0001; p = 0.0001. Number of transferred patients: 16. 
                                         IV stage IIIc stage 21-18=3 
IIIc stage 21-18=3 
IIIc stage 21-11=10 
IIIc stage 10-10=0. 
       Another interesting event was the comparison group in the same revision (what medical researchers 
usually did). The classification mission is to provide differences in the survival rates between the groups. So 
first, the 6th revision. As far as it is able to divide into groups of patients with gastric cancer was 
significantly different survival. Going forward, we must say that the second classification of patients in our 
sample proved to be qualitatively better level. 
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        Table 6. Reliability of differences between those survival curves, created by 6
th
 Classification. 
Differences in survival of subgroups according 6th revision of the UICC 
There is differences in survival  There is no differences in 
survival 
р<0,05 р<0,01 р>0,05 
T2No T2N1 
р= 0,033 
T2No T2N2,  
р= 0,0088 
T2N2 T2N1,  
р= 0,62 
T2N2 T3N2 
 р= 0,01 
T2No T3N1,  
р= 0,00029 
T2No T3No,  
р= 0,1 
T3N2 T3No 
 р= 0,039 
T3N1 T2N1,  
р= 0,00016 
T3No T2N1,  
р= 0,66 
T3N3 T4No 
р= 0,0148 
T2N2  T3N1,  
р= 0,0005 
T3No T2N2,  
р= 0,85 
T2No T4N1 
 р= 0,041 
T3No T3N1,  
р= 0,0002 
T4No T2N1, 
 р= 0,27 
T4N2 T2No 
 р= 0,028 
T2No  T3N2, 
 р= 0,0001 
T2N2 T4No, 
 р= 0,55 
T3N2 T4N2 
р= 0,035 
T3N2  T3N1,  
р= 0,0002 
T4No T3No,  
р= 0,13 
T4N3 T4N1 
р= 0,0199 
T2No  T3N3, 
 р= 0,0003 
T3N3 T3N2,  
р= 0,46 
T4N3 T2N2 
р= 0,0125 
T3N3  T2N1,  
р= 0,0006 
T4No T3N2,  
р= 0,12 
T4N3 T2N1 
р= 0,024 
T3N3  T2N2,  
р= 0,0002 
T4N1 T4No,  
р= 0,24 
 T3N3  T3No,  
р= 0,00015 
T3No T4N1,  
р= 0,72 
 T3N3  T3N1, 
р= 0,0001 
T2N2 T4N1,  
р= 0,86 
 T4No  T2No,  
р= 0,0013 
T4N1 T2N1,  
р= 0,94 
 T4No  T3N1,  
р= 0,0001 
T4N2 T2N1,  
р= 0,76 
 T3N3  T4N1,  
р= 0,00044 
T4N2 T2N2,  
р= 0,59 
 T3N2  T4N1,  
р= 0,0092 
T4N2 T3No,  
р= 0,49 
 T4N1  T3N1,  
р= 0,0001 
T4N2 T4No,  
р= 0,48 
 T4No  T2No,  
р= 0,0013 
T4N1 T4N2,  
р= 0,5 
 T2N2  T3N2, 
 р= 0,0057 
T4N3 T4No,  
р= 0,35 
 T4N2  T3N1,  
р= 0,0001 
T4N3 T3N3,  
р= 0,23 
 T4N2  T3N3,  
р= 0,0032 
T4N3 T3N2,  
р= 0,68 
 T4No  T2No,  
р= 0,0013 
 
 T4N3  T3N1,  
р= 0,0001 
 
 T4N3  T3No,  
р= 0,0086 
 
 T4N3  T2No,  
р= 0,0002 
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         Thus, a high mathematical precision was able to show that most of the groups of patients created the 
6th revision of the classification TNM, statistically different. From our point of view, this is the goal of 
creating a classification: the creation of a classification system that with its help you can create groups, 
differing from each other by objective evidence. In this case we observe and analyze the differences in 
survival between groups. 21 pairs of survival curves were not differences compared 25 pairs of survival 
curves of RG - ultra-high power differences p <0.01, and in many cases, p <0.001 and p <0.0001. 10 pairs of 
survival curves were statistically significant differences between them with the power of p <0.05. Charts are 
not given, so as not to clutter up the story. 
      "Step" survival curves between them and the presence of "crossroads" in the calculation did not matter. 
Calculation was based on D.R.Cox, not by the log-rank and Kaplan-Meier for which such "descriptive" 
characteristics are important. For Cox proportional hazards model visualization graphs critical value almost 
does not matter. Survival curves in real life, may intersect with each other several times. Example. 
 
        
P=0,6584 
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Table 7. Stages calculate survival rate for 3A stage according to different TNM systems. 
Control group  Main group 
Table of 
survival 
Month % of survived Table of 
survival 
Month % of survived 
6,24,1 
12,38,1 
14,61,1 
9,26,1 
7,25,1 
9,27,1 
8,26,1 
5,17,1 
2,9,1 
3,12,1 
15,78,1 
11,36,1 
13,45,1 
1,5,1 
10,24,0 
4,38,0 
2,61,0 
7,26,0 
9,25,0 
7,27,0 
8,26,0 
11,17,0 
14,9,0 
13,12,0 
1,78,0 
5,36,0 
3,45,0 
15,5,0 
5.0000 
9.0000 
12.0000 
17.0000 
24.0000 
25.0000 
26.0000 
27.0000 
36.0000 
38.0000 
45.0000 
61.0000 
78.0000 
0.9644 
0.9273 
0.8887 
0.8484 
0.8060 
0.7613 
0.7613 
0.6159 
0.5543 
0.4849 
0.4039 
0.3023 
0.1484 
1,10,1 
10,37,1 
11,37,1 
14,74,1 
2,12,1 
7,24,1 
5,17,1 
6,18,1 
4,15,1 
3,12,1 
8,36,1 
9,36,1 
13,57,1 
12,47,1 
13,10,0 
4,37,0 
3,37,0 
10,74,0 
12,12,0 
7,24,0 
9,17,0 
8,18,0 
10,15,0 
11,12,0 
6,36,0 
5,36,0 
1,57,0 
2,47,0 
10.0000 
12.0000 
15.0000 
17.0000 
18.0000 
24.0000 
36.0000 
37.0000 
47.0000 
57.0000 
74.0000 
0.9645 
0.8937 
0.8531 
0.8105 
0.7655 
0.7177 
0.6220 
0.5084 
0.4224 
0.3132 
0.1409 
Coefficients, Std Errs, Signif, and Conf Intervs... 
   Var        Coeff.    StdErr       p       Lo95%     
Hi95% 
     1        0.0089    0.0546    0.8701   -0.0975    
0.1153 
Coefficients, Std Errs, Signif, and Conf 
Intervs... 
   Var        Coeff.    StdErr       p       Lo95%     
Hi95% 
     1       -0.0381    0.0652    0.5590   -
0.1653    0.0891 
 
       The next step was to conduct a similar analysis for the 7th TNM classification. What if this same group 
of patients with gastric cancer, be classified not by the 6th, but now by the 7th revision of the classification. 
Then to compare how will differ obtained TN-group (Index M is always "0" in this case, since it was only 
patients with local disease). 
       To achieve greater purity of this experiment, the patients were stratified randomly into two groups, in 
which comparisons were made. Here's present what happened. 
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 Table 8. The interaction between stages and the significance of differences in the survival of subgroups 
TNM classification of gastric cancer patients 7th revision of the UICC 
 1st group 
 
 2nd group 
1 T4аNo T4аN1 р= 0,23>0,05 T4аNo T4аN1 р= 0,88>0,05 
2 T4аNо T4bNo р= 0,42>0,05 T4аNо T4bNo р= 0,75>0,05 
3 T4aN1  T4bNo р= 0,71>0,05 T4aN1  T4bNo р= 0,87>0,05 
4 T4bNo  T4bN1 р= 0,56>0,05 T4bNo T4bN1 р= 0,72>0,05 
5 T4bN1   T4aN1 р= 0,84>0,05 T4bN1  T4aN1 р= 0,60>0,05 
6 T4bN1  T4aNo р= 0,31>0,05 T4bN1 T4aNo р= 0,42>0,05 
7 T4аNo  T4аN2 = 0,12>0,05 T4аN2 T4bN1 р= 0,61>0,05 
8 T4аN2  T4aN1 р= 0,47>0,05 T4аN2 T4bNo р= 0,36>0,05 
9 T4aN2  T4bNo р= 0,28>0,05 T4aN2 T4aN1 р= 0,29>0,05 
10 T4bN1  T4aN2 р= 0,64>0,05 T4aN2 T4aNo р= 0,13>0,05 
11 T4bN2  T4aN2 р= 0,46>0,05 T4bN2 T4aN2 р= 0,45>0,05 
12 T4bN2  T4bN1 р= 0,74>0,05 T4bN2 T4bN1 р= 0,19>0,05 
13 T4bN2  T4bNo р= 0,89>0,05 T4bN2 T4bNo р= 0,99>0,05 
14 T4bN2 T4aN1 р= 0,87>0,05 T4bN2 T4aN1 р= 0,91>0,05 
15 T4bN2 T4aNo р= 0,61>0,05 T4bN2  T4aNo р= 0,66>0,05 
16 T4aN3  T4bN2 р= 0,20>0,05 T4aN3  T4bN2 р= 0,44>0,05 
17 T4aN3 T4aN2 р= 0,21>0,05 T4aN3  T4aN2 р= 0,87>0,05 
18 T4aN3 T4bN1 р= 0,41>0,05 T4aN3  T4bN1 р= 0,051>0,05 
19 T4аN3 T4bNo р= 0,73>0,05 T4аN3  T4bNo р= 0,39>0,05 
20 T4аN3 T4aN1 р= 0,51>0,05 T4аN3  T4aN1 р= 0,33>0,05 
21 T4aN3  T4aNo р= 0,96>0,05 T4aN3  T4aNo р= 0,21>0,05 
22 T4bN3  T4aNo р= 0,41>0,05 T4bN3  T4aNo р= 0,64>0,05 
23 T4bN3  T4aN1 р= 0,89>0,05 T4bN3  T4aN1 р= 0,89>0,05 
24 T4bN3 T4bNo р= 0,66>0,05 T4bN3  T4bNo р= 0,66>0,05 
25 T4bN3 T4bN1 р= 0,96>0,05 T4bN3  T4bN1 р= 0,54>0,05 
26 T4bN3  T4aN2 р= 0,65>0,05 T4bN3  T4aN2 р= 0,29>0,05 
27 T4bN3  T4bN2 р= 0,59>0,05 T4bN3  T4bN2 р= 0,93>0,05 
28 T4bN3  T4aN3 р= 0,49>0,05 T4bN3  T4aN3 р= 0,34>0,05 
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        As you remember, comparing survival rates classified by the 6th edition of the classification of patients 
managed to obtain three groups. Groups differed in the strength of significant differences in survival in 
patients with gastric cancer. Groups have 21, 25 and 10 sub-groups in which the survival curves were 
compared by p-criteria. Thus the power of manufactured classification can be appreciated be the particular 
criteria: its capacity to demonstrate the survival difference between those groups mathematically. 
        Unfortunately, this same group of patients classified now on the 7th TNM classification, the differences 
in survival rates between similar groups-family, we could not fix. This fact is reflected in Table 8. The 
probability of finding differences between the stratified 7th classification groups was always less than 95%. 
But this is not enough for biomedical research. 
      Present work has only a research interest and in any case not intended to criticism classifications. We 
hope that in the recruitment process obtain more material to trace brand new, more interesting trends. 
Although the number of our group was comparable with two of those four known studies: 188 ours against 
295 Sumin Chae et al., 266 Kim SS et al., 609 Shiro Kikuchi et al., 2090 patients Daniele Marrelli and 
colleagues. 
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